RareStone
Developing and commercializing therapies for rare diseases in Asia.
Sector
Life SciencesCategory
TherapeuticsLocation
Shanghai, ChinaInitial Investment
2020
Developing and commercializing therapies for rare diseases in Asia.
RareStone (formerly Citrine Medicine) is a rare disease-focused therapeutics company focused on the Greater China market that was co-founded by Eight Roads Ventures, F-Prime Capital and Vivo Capital. RareStone is dedicated to improving the lives of rare disease patients by making diagnosis and essential treatments available and accessible for those who need them.